pathology microbiology and immunology Archives
Jun. 29, 2017—A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine.
Mar. 16, 2017—The Rockefeller University’s Paul Bieniasz, Ph.D., center, here with Vanderbilt’s Samuel Santoro, Ph.D., left, and Christopher Aiken, Ph.D., discussed his research on retroviruses at his recent Flexner Discovery Lecture, which was sponsored by the Department of Pathology, Microbiology and Immunology.
Mar. 2, 2017—James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017 recipient of the Stanley J. Korsmeyer Award given by the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected honor societies for physician-scientists.
Mar. 2, 2017—Paul Bieniasz, Ph.D., a pioneer in the study of retroviruses, will deliver the next Flexner Discovery Lecture on Thursday, March 9.
Feb. 22, 2017—Scientists at Vanderbilt University have created a three-dimensional organ-on-a-chip that can mimic the heart’s amazing biomechanical properties in order to study cardiac disease, develop heart drugs.